Loading clinical trials...
Loading clinical trials...
A Phase II Non-blinded Randomized Study Comparing External Beam Radiotherapy (EBRT), 177Lu-PSMA-617, and Short Term Androgen Deprivation Therapy (ADT) Versus EBRT and Long Term ADT in Men With High Risk Localized Prostate Cancer
Conditions
Interventions
EBRT + 6 mo ADT + 177Lu-PSMA-617
EBRT + 24 mo ADT
Locations
1
United States
Johns Hopkins University
Baltimore, Maryland, United States
Start Date
April 1, 2026
Primary Completion Date
April 1, 2032
Completion Date
April 1, 2033
Last Updated
April 24, 2026
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions